Skip to main content
RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc. — Investor Relations & Filings

Ticker · RAPT ISIN · US75382E1091 LEI · 549300MB473BIU78ES48 US Manufacturing
Open in API
Filings indexed 534 across all filing types
Latest filing 2025-07-08 Investor Presentation
Country US United States of America
Listing US RAPT

About RAPT Therapeutics, Inc.

https://rapt.com/

RAPT Therapeutics, Inc. is a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with inflammatory and immunologic diseases. The company's scientific approach involves developing therapeutics that intelligently target key drivers of the immune system. Its pipeline includes ozureprubart (RPT904), a long-acting anti-IgE antibody being evaluated in a Phase 2b clinical trial for the treatment of food allergies.

Recent filings

Filing Released Lang Actions
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions that the filing includes an investor presentation (Corporate Presentation) as Exhibit 99.1. The document states that the presentation is being furnished and is not considered "filed" for certain regulatory purposes, indicating this is an announcement of the presentation rather than the presentation itself. The document length is 3371 characters, which is relatively short and consistent with a filing announcing or furnishing a presentation rather than the full presentation content. The key phrase "investor presentation slides (the 'Corporate Presentation') attached hereto as Exhibit 99.1" and the description of the presentation as something the company "may use from time to time in conversations with investors and analysts" aligns with the definition of an Investor Presentation (IP). Therefore, the filing type is Investor Presentation (IP).
2025-07-08 English
Director's Dealing 2025
Director's Dealing
2025-07-01 English
Director's Dealing 2025
Director's Dealing
2025-07-01 English
Director's Dealing 2025
Director's Dealing
2025-06-24 English
Director's Dealing 2025
Director's Dealing
2025-06-24 English
Director's Dealing 2025
Director's Dealing
2025-06-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.